# Belite Bio (BLTE.US)

Canonical: https://gigainvestors.com/s/BLTE

Analysis as of: 2026-10-16T07:26:59.925Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $152.62 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

- [Lee Ainslie](https://gigainvestors.com/mc): tracked 13F investor; follow the investor page for holding quarter and amounts.

## Price story

Up 307% since Oct 2023 · "BLTE Stock Rises as FDA Grants Priority Review to Tinlarebant NDA" (finance.yahoo.com, Aug 2026)

Story as of 2026-10-16T09:58:24.851Z; price observation 2026-10-15.

- 2025-08-12: Belite Bio Q2 2025 presentation: expenses rise as clinical trials advance ([investing.com](https://www.investing.com/news/company-news/belite-bio-q2-2025-presentation-expenses-rise-as-clinical-trials-advance-93CH-4184066))

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### Where the cash goes

Paid no dividends in 6 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-31); Dividend observations: [[2020,0],[2021,0],[2022,0],[2023,0],[2024,0],[2025,0]]. Zero only counted when supported by a complete cash-flow statement.

### Are managers owners

Insiders own 43.6% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); BLTE.US SharesStats.PercentInsiders = 43.644 percentage points; cache date 2026-10-16.

### What the price says

The price is 6.6 times net assets; cash earnings are negative.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-31); Closing price 152.62 USD; reporting-to-trading FX 1; FY2025 net assets per share 22.97341297196984; price multiple 6.643331584480445. FY2025 cash earnings/share -2.3055826556972714. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2022-04: $10.59 per share

- 2022-05: $15.12 per share

- 2022-06: $31.14 per share

- 2022-07: $33.60 per share

- 2022-08: $32.11 per share

- 2022-09: $33.55 per share

- 2022-10: $29.07 per share

- 2022-11: $32.77 per share

- 2022-12: $30.15 per share

- 2023-01: $29.89 per share

- 2023-02: $33.10 per share

- 2023-03: $29.90 per share

- 2023-04: $28.93 per share

- 2023-05: $16.49 per share

- 2023-06: $14.29 per share

- 2023-07: $23.22 per share

- 2023-08: $34.35 per share

- 2023-09: $31.85 per share

- 2023-10: $37.51 per share

- 2023-11: $42.07 per share

- 2023-12: $45.75 per share

- 2024-01: $43.43 per share

- 2024-02: $46.25 per share

- 2024-03: $38.37 per share

- 2024-04: $40.60 per share

- 2024-05: $48.95 per share

- 2024-06: $45.68 per share

- 2024-07: $49.50 per share

- 2024-08: $48.68 per share

- 2024-09: $46.88 per share

- 2024-10: $66.61 per share

- 2024-11: $63.26 per share

- 2024-12: $63.10 per share

- 2025-01: $58.04 per share

- 2025-02: $57.20 per share

- 2025-03: $66.22 per share

- 2025-04: $61.48 per share

- 2025-05: $64.87 per share

- 2025-06: $57.70 per share

- 2025-07: $65.01 per share

- 2025-08: $63.03 per share

- 2025-09: $74.00 per share

- 2025-10: $105.91 per share

- 2025-11: $137.44 per share

- 2025-12: $159.96 per share

- 2026-01: $169.00 per share

- 2026-02: $190.30 per share

- 2026-03: $159.44 per share

- 2026-04: $159.16 per share

- 2026-05: $144.18 per share

- 2026-06: $153.99 per share

- 2026-07: $158.61 per share

- 2026-08: $155.71 per share

- 2026-09: $169.82 per share

- 2026-10: $152.62 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 20-F filing](https://www.sec.gov/Archives/edgar/data/1889109/000110465926037374/blte-20251231x20f.htm); period 2025-12-31, filed 2026-03-31.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations

- [Lee Ainslie](https://gigainvestors.com/mc): 396,311 BLTE shares; USD 61,026,000 reported position value; 0.55% of portfolio; new; quarter 2026 Q2.

# BLTE — Belite Bio Inc ADR

Held by 1 investor · USD 61,026,000 total · 2026 Q2 · reported price USD 153.99 (split-adjusted).
Page: https://gigainvestors.com/s/BLTE

## Holders (2026 Q2)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| Lee Ainslie (https://gigainvestors.com/mc) | USD 61,026,000 | 0.6% | new |

## Total held by quarter

- 2026 Q2: USD 61,026,000 · 1 holder · USD 153.99